【C.S Group】: Launches Antcin A-Based Veterinary Drug Initiative Across Taiwan and China

---
【C.S Group】: Launches Antcin A-Based Veterinary Drug Initiative Across Taiwan and China
Vote:
0 0
Previous Nisun International Enterprise Development Group Co., Ltd Reports Full Year 2024 Financial Results
Next KT Corp. Files 2024 Annual Report on Form 20-F

Related News

【C.S Group】: Antcin A and Steroid Combination Shows Synergistic Potential in Preliminary Study

【C.S】 Group Targets Global Pet Medication Market with Groundbreaking Taiwanofungus-Based New Drug

China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment

ASG Announces the Completion of pre-IND meeting with FDA for Lead Drug Beta1, Receiving Encouraging Feedback

J INTS BIO, Oral TKI 'JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC

OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab

menu
menu